Introduction
Prioritizations in health care are becoming more and more difficult as the pressure to contain costs increases. Epiphora is rarely considered a significant cause of visual disability as it seldom affects visual acuity (VA) in test situations and is therefore often assigned a lower priority. However, epiphora leads to considerable patient discomfort due to blurring of vision, caused presumably by an ever-changing and irregular tear film (Kafil-Hussain & Khooshebah 2005) . Clinicians often hear about difficulties in down gaze or reading because of an increased tear meniscus, problems with distance judgement and complaints about having sore skin from persistent wiping and a crying appearance that is socially embarrassing (Kafil-Hussain & Khooshebah 2005; Fayers et al. 2009; Shin et al. 2015 , Jutley et al. 2013 .
If a watery eye is caused by lacrimal passage obstruction there are effective treatment options, for example DCR, which has a 83-97% success rate (Fayers et al. 2009; Marcet et al. 2014 ), or lacrimal intubation, which has a 59-76% success rate (Kashkouli et al. 2005; Andalib et al. 2014) . Both these treatments have also been shown to improve the patients' quality of life (Kabata et al. 2011; Jutley et al. 2013) .
In deciding how to prioritize costs, it is important to know how epiphora problems affect everyday life in comparison with other diseases that disturb visual function.
In vision-related disorders, it is increasingly recognized that VA is not the only relevant measure of the degree of severity of a disease. Since 1995, the Swedish NCR has included a preoperative questionnaire to measure patients' self-assessed visual function, and more recently this has been the Catquest-9SF (Lundstrom & Pesudovs 2009; Lundstrom et al. 2011) . All centres performing cataract surgery in Sweden report approximately 97% of their cases to the NCR (Zetterstrom et al. 2015) . Every year in March the pre and postoperative results obtained with the Catquest-9SF are reported as part of a routine follow-up evaluation. Approximately 50% of the surgical units in Sweden contribute to this register. This allows the NCR to provide excellent statistics and as cataract extraction is the most common ocular surgery, it is a relevant reference group.
The aims of this study were to validate the use of Catquest-9SF for epiphora patients, to quantify the visual disability experienced by this group and to compare it with the visual disability reported to the NCR by patients listed for cataract surgery.
Materials and Methods

Patients
Consecutively encountered patients with acquired lacrimal stenosis who were listed for DCR or lacrimal intubation between January 2013 and May 2014 at the St Erik Eye Hospital, Stockholm, Sweden, agreed to complete the Catquest-9SF during their preoperative visit. Their main complaint was epiphora, and the diagnosis of lacrimal obstruction was based on examination with lacrimal irrigation. Patients with other significant causes of epiphora, for example, eyelid malposition or trichiasis, were excluded from the study. Exclusion criteria also included inability to answer the questionnaire either due to mental disabilities/dementia or language problems, age under 18 years, congenital or functional nasolacrimal duct obstruction, lacrimal obstruction attributed to sarcoidosis, granulomatous polyangiitis (formerly known as Wegner) tumour, trauma or chemotherapy. No patients were excluded due to comorbidity with other vision-related disorders.
The reference group consisted of all patients in the NCR cataract register described above who had completed the Catquest-9SF questionnaire during the month of March 2013.
The study was approved by the relevant Ethics Committee and conforms to the Helsinki Declaration.
Catquest-9SF questionnaire
The Catquest-9SF includes nine items, two global assessment items and seven disability items (Table 1) . It was developed for and validated on cataract patients to measure each patient 0 s selfassessed visual disability, by which is meant the restrictions and difficulties experienced in everyday tasks due to their impaired visual function (Lundstrom & Pesudovs 2009; Lundstrom et al. 2011) . Each item has four response options for the perceived difficulty level; for the second item the options are 1 = 'Yes, very satisfied'; 2 = 'Yes, fairly satisfied'; 3 = 'No, rather dissatisfied'; and 4 = 'No, very dissatisfied'. For the other items the categories are 1 = 'No, no problems'; 2 = 'Yes, some problems'; 3 = 'Yes, great problems'; and 4 = 'Yes, very great problems'. For each item a lower score is better, and a higher score is worse. All items include an option of 'Cannot say'.
The items in the Catquest-9SF were not developed for patients with lacrimal obstruction, but the problems experienced by patients with epiphora are sufficiently similar for the questionnaire to be appropriate.
The original Swedish version of the Catquest-9SF questionnaire was completed by all patients, but the results are reported here in terms of the official British English version.
Statistical analysis
Rasch analysis was employed to validate the use of Catquest-9SF on patients with epiphora by testing the following psychometric properties of the questionnaire on this group of patients: rating scale, ability to discriminate different strata of person ability, item fit statistics, targeting precision of the instrument to the studied population and unidimensionality. The WINSTEPS programme (version 3.91.0; Winsteps, Beaverton, OR, USA) was used for all Rasch analyses in this study. Rasch analysis was subsequently used to transform the ordinal raw data into a Rasch scale (logit). This is a linear scale from À5.43 logits (no activity limitations) to +5.01 logits (severe activity limitations). As there is no defined minimal clinically relevant difference for comparing patients with epiphora and patients with cataract, this was assumed to be AE1 logit, that is, that a difference in subjective symptom rating less than 1/10th of the scale was clinically insignificant.
Results
Of the 72 patients with confirmed lacrimal obstruction who answered the Catquest-9SF questionnaire 20 (28%) were men. Mean age was 59.5 years (range 19-88 years). The response rate was 100% (no patient declined to participate). Only one patient had bilateral obstruction.
Rasch analysis showed that the Catquest-9SF had a misfit for Item 4 (ability to recognize the faces of the people you meet) when measuring subjective visual function in patients with epiphora (Table 2 ). After this item was excluded a new analysis showed acceptable fit statistics for this group of patients (Table 3) with good psychometric qualities as follows: The category thresholds were ordered, person separation was 2.93 (aim >2) and person separation reliability was 0.90 (aim >0.7). The remaining items showed item fit to a single overall construct (infit range 0.66-1.26; outfit range 0.60-1.19) and unidimensionality (variance explained by measures = 67.6% (aim >60%) and unexplained variance in first contrast eigenvalue 1.6 (aim <2)). The item map showed that the patients' mean ability was larger than the mean difficulty of the items (item mean 0; person mean À0.82).
During the month of March 2013, a total of 3625 patients were added to the NCR cataract after completing the Catquest-9SF before and after surgery, 2096 for 1st eye cataract surgery and 1529 for 2nd eye cataract surgery. In the 1st eye group there were 40% men, and the mean age was 73.6 years (range 20-98). The 2nd eye group consisted of 38% men and had a mean age of 74.6 years (range 41-98). Table 4 shows the Catquest-9SF score for these three groups, respectively.
As previously stated, we assumed that a clinically relevant difference would equate to more than AE1 on the Rasch scale. An equivalence test was made, and the confidence interval was calculated for the difference in mean Rasch score between the epiphora group and the 2nd eye cataract group. Normally, a confidence interval should not include zero to be significant but in this instance equivalence and not difference where studied. The lower limit of the 95% confidence interval was À0.55 and the upper limit 0.44. This confidence interval includes zero, and the upper and lower limits are less than a supposedly clinically relevant difference. Even the 99% confidence interval (lower limit À0.7, upper limit 0.6) are within AE1. Calculation was also made for the 95% confidence interval on the difference in mean Rasch score between patients with epiphora and patients listed for 1st eye cataract surgery, but this did not include zero (lower limit À0.68, upper limit À0.51).
Discussion
In this study we can show, using Rasch analysis, that the Catquest-9SF is a valid measure of activity limitations in the daily life of patients with epiphora after the exclusion of Item 4 (facial recognition). It may be that this item showed an item misfit because facial recognition is dependent not only on visual function but also on higher cerebral functions. It should be noted that the Catquest-9SF questionnaire was developed for patients with cataract and activity limitations in daily life. This means that it does not take into account ocular symptoms or social wellbeing such as the more epiphoraspecific complaints of sore eyelid skin, and the social embarrassment caused by constantly appearing to be crying. If a more complete evaluation of the impact of epiphora symptoms on everyday life is required a more epiphora-specific instrument should be employed, for example, the NDLO-SS (Penttil€ a et al. 2014) or Lac-Q (Mistry et al. 2011) . However, the use of Catquest-9SF allows comparison with the degree of activity limitations reported preoperatively by patients with cataract in the NCR register.
The NCR performs an annual follow-up of patients during the month of March and calculates the effect of surgery on their visual function. Our validation of the Catquest-9SF enables further studies on patients with epiphora, not only to quantify their visual disability but to investigate the benefits of lacrimal surgery in comparison with those of cataract extraction.
We conclude that the reported activity limitations due to visual disability in the epiphora group and the 2nd eye cataract group were equally severe, as the 95% confidence interval of the difference between the two groups was well within one step of the Rasch scale. The mean Rasch score of patients awaiting 1st eye cataract surgery was not comparable with that of the epiphora patients. This result is in agreement with the only previously published comparison of the perceived problems in daily life between patients with epiphora and patients with cataract. (Kafil-Hussain & Khooshebah 2005) . These authors showed, through the use of the VF-14 questionnaire, that patients with epiphora suffer the same if not more disablement compared to patients awaiting 2nd eye cataract surgery. This questions the insignificance usually attributed to epiphora symptoms, as surgery for 2nd eye cataract is rarely questioned even if there are no problems with binocularity or anisometropia.
A limitation of our study is that comorbidity with other disorders affecting visual functions was not taken into account in the patients with epiphora. However, this limitation also applies, and perhaps to a greater extent, to the patients with cataract, as their mean age was more than 10 years higher. The mean age of the patients with epiphora in our study was below the usual retirement age in Sweden so their reduced visual function thus affects the working life of the majority of such patients.
Finally, one should remember that this study compares two cohorts with nothing else in common than a disease affecting visual function. On the other hand, one could argue that this is exactly the difficult comparison that those responsible for health care prioritizations must make.
In summary, this study shows that an 8-item version of the Catquest-9SF is a valid instrument (according to Rasch analysis) for measuring visionrelated activity limitations in daily life for patients with epiphora. It also shows that patients with epiphora experience activity limitations to the same degree as is reported by patients listed for 2nd eye cataract surgery. We hope that our findings can raise awareness that epiphora is not only of cosmetic concern but a medical problem that affects everyday life.
